4-((5-Bromo-2-methylphenyl)sulfonyl)morpholine, 98%, 250mg

M-TOLYLOXYACETONITRILE, 97.0%, 1g

1-ethyl-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 5g

4-Methoxy-4'-fluorochalcone, 98.0%, 5g

(3-METHOXYPYRIDAZIN-4-YL)METHANOL, 95.0%, 250mg

2,4-Dichloro-1,3,5-triazine, 95.0%, 1g

3-Amino-N-(2,5-dimethoxyphenyl)benzamide, 95.0%, 10g

GLYCIDYL (R)-(-)-4-NITROBENZENESULFONATE, 97.0%, 100g

3-(1H-benzimidazol-1-yl)propanoic acid dihydrochloride, 95.0%, 1g

Anhídrido ftálico, mínimo 98%, para síntesis, 2,5 kg, envase de plástico.

Benzyl 2-Naphthyl Ether>98.0%(GC)25g

SODIUM 3-HYDROXYBENZENESULFONATE, 95.0%, 5g

2,4,6-Trimethylbenzoic acid, 95.0%, 25g